Show the Working

Invest in Public Health and 'Health Creation Unit'

Liberal Democrat · what the evidence says

An independent, source-checked look at Liberal Democrat’s policy “Invest in Public Health and 'Health Creation Unit'” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.

Public finances & the next generation — Mixed picture

minor · low confidence

Increasing the Public Health Grant adds near-term spending pressure without a confirmed funding source, but prevention is projected to be far cheaper per health gain than NHS treatment, offering a potential long-run fiscal dividend. Whether the savings materialise at scale — and whether spending is funded or borrowed — is genuinely unknown.

The evidence

Biggest unknown: Whether the additional Public Health Grant spending is funded from existing budgets or new borrowing, and whether prevention savings to the NHS materialise at sufficient scale to offset the upfront cost.

Our reading: For O12, the key question is whether this policy improves or worsens the long-run debt path. There are two competing effects. Near-term, the policy adds expenditure — an increased Public Health Grant on top of the £3.858bn current level — without specifying a funding source. If financed by borrowing, this adds to the near-term deficit; if from existing budgets, it is fiscally neutral upfront but displaces other spending. The policy text is silent on this. Long-term, the projected cost-effectiveness of public health relative to NHS treatment (£3,800 vs £13,500 per QALY) and the OBR's own projections of rising health spending over decades create a credible fiscal case: investing in prevention now could reduce future NHS demand and working-age economic inactivity, easing the long-run spending trajectory. However, this is a projection, not a certainty. The previous UK cross-government strategy (2000-2010) delivered mixed results — some gains in life expectancy but no improvement in several health dimensions — meaning the fiscal dividend cannot be assumed. The Health Creation Unit itself is a coordination mechanism with no committed budget or statutory powers cited in the evidence, limiting its independent fiscal impact. On balance, the near-term effect is a modest unfunded spending pressure (worsens slightly), while the long-term effect is a plausible but uncertain fiscal improvement if prevention delivers. This is genuinely mixed with low confidence: the direction of the long-run effect depends on delivery, political durability, and funding source — none of which are resolved by the evidence provided.

Inequality & fair shares — Helps

minor · low confidence

Targeting extra public health money at the most deprived communities and setting up a cross-government health unit could narrow the health-driven inequality gap over the long run, but past cross-government strategies had patchy results and the committed funding is modest relative to a decade of cuts.

The evidence

Biggest unknown: Whether sustained political commitment and sufficient funding materialise — past cross-government health strategies succeeded on some inequality metrics but failed on others, and the policy's redistributive impact depends entirely on how large the ring-fenced deprived-area share actually is.

Our reading: The policy has a clear redistributive design: it explicitly directs a portion of increased public health funding toward the most deprived communities, which the evidence shows have borne the steepest cuts over the past decade and face the largest health inequality burdens. Since health inequalities track income and wealth inequalities closely — with the poorest tenth of the population facing major illness a decade earlier and 80% of projected ill-health growth concentrated in deprived areas — channelling resources there would, if delivered, modestly narrow a material dimension of the inequality gap. The cross-government Health Creation Unit adds structural weight by embedding redistribution logic into policy formation. The historical analogue (the 2000–2010 cross-government strategy) supports cautious optimism: it did reduce life expectancy and infant mortality gaps. But that same evidence base shows failure on mental health, self-reported health, and long-term conditions — so the mechanism works selectively, not universally. The 2025–26 grant uplift (3% real terms) only partially reverses a 26% real-terms per-person cut over a decade, so the absolute scale of new redistribution is modest. The 'Health Creation Unit' is an aspirational coordination mechanism with few existing systemic drivers behind it, making delivery uncertain. On balance, the policy's targeted design and historical precedent point toward a genuine but minor improvement in inequality indicators over the long term — contingent on sustained commitment and meaningful ring-fencing, neither of which is guaranteed by the policy text alone.

Healthcare — Helps

moderate · moderate confidence

Increasing the Public Health Grant and creating a cross-government health unit should help people stay healthier for longer and reduce pressure on the NHS, but the gains will take years to materialise and past similar efforts had mixed results on some health outcomes.

The evidence

Biggest unknown: Whether sustained political commitment and sufficient funding will be maintained long enough to overcome a decade of cuts and shift the system meaningfully toward prevention.

Our reading: The policy addresses a well-documented problem: a decade of real-terms cuts to public health funding has left preventative services severely depleted relative to NHS acute spending. Reversing the grant decline and targeting funds at the most deprived communities directly addresses a measurable gap. The cost-effectiveness evidence strongly favours prevention — public health interventions deliver a QALY at a fraction of the NHS cost — so more prevention spending should, over the long term, improve population health and reduce NHS waiting-list pressure. The Health Creation Unit concept aligns with evidence that cross-government coordination can reduce health inequalities, as shown by the 2000–2010 strategy's progress on life expectancy and infant mortality. However, that same strategy also showed limited or worsening results on mental health and long-term conditions, meaning the approach is not a guaranteed fix across all dimensions. The structural risk is real: ICSs face acute financial pressures that may crowd out prevention, there are currently few systemic drivers to embed health-creation practices, and sustained political commitment is historically hard to maintain. The time horizon is necessarily long-term — prevention investments take years to show measurable waiting-list or capacity effects. On balance, the direction is positive: the policy directly addresses a stated funding gap, targets the most deprived, and draws on a model with partial historical success. But magnitude is moderate rather than major because the funding uplift must overcome a large accumulated deficit, implementation risks are significant, and past cross-government strategies had inconsistent results.